FDA Adverse Event Malfunction Summary report: N

N/A (INCIDENT OCCURRED IN THE WAREHOUSE)

MDR report key: 1907847 · Received November 24, 2010

Report

Report Number
1061932-2010-00228
Event Type
Malfunction
Date Received
November 24, 2010
Date of Event
October 28, 2010
Report Date
October 28, 2010
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
CLASS1EXEMPT
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BCI MANUFACTURING HAS CONFIRMED THAT THERE IS NO OPPORTUNITY FOR BLOOD CONTACT DURING THE MANUFACTURING PROCESS (FILLING, CAPPING, LABELING, OR KIT PACKAGING) OF THE ZAP-OGLOBIN II LYTIC REAGENT. BLOOD CONTROLS AND CALIBRATORS MANUFACTURED AT (B)(4) ARE FILLED, CAPPED, LABELED, AND THE KITS PACKAGED AT SEPARATE BUILDINGS FROM WHERE THE REAGENT IS PRODUCED. INCOMING DEPARTMENT HAS INSPECTED SAMPLES FROM CURRENT INVENTORY AND NO LABELS EXHIBITED THE SPLATTERING MARKING ON THEM. SERVICE WAS NOT DISPATCHED FOR THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) STATING THAT THEY FOUND A ZAP-OGLOBIN II LYTIC REAGENT CONTAINER THAT CONTAINED SPLATTERING RED MARKING, WHEN UNPACKING A SHIPMENT. THE CUSTOMER REPORTED POSSIBLE BLOOD SPLASHED ONTO THE PRODUCT LABELING. THE CUSTOMER REPORTED THAT SINCE THE LABEL WAS DRY WHEN FOUND, IT WAS PUT INTO A PLASTIC BAG BEFORE SCRAPPING IT. THE CUSTOMER CONFIRMED THAT THE OTHER PRODUCTS PACKED WITH THIS ITEM DID NOT HAVE THIS SYMPTOM. THERE WAS NO BLOOD EXPOSURE TO EYES, MOUTH, OR OPEN WOUNDS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 N/A (INCIDENT OCCURRED IN THE WAREHOUSE) N/A (INCIDENT OCCURRED IN THE WAREHOUSE) GKZ BECKMAN COULTER, INC. N/A 129012F

Patients

Seq Age Sex Outcome Treatment
1